| Literature DB >> 32077054 |
Huiying Wang1, Vivian L Weiss2, Robert D Hoffman2, Ty Abel2, Richard H Ho3, Scott C Borinstein3, Kyle Mannion4, Julia A Bridge5, Jennifer Black6, Jiancong Liang7,8.
Abstract
NUT (midline) carcinoma is a rare, highly aggressive, poorly differentiated carcinoma that characteristically harbors a rearrangement of the NUTM1 gene. Most of these tumors occur in adolescents and young adults, arise from the midline structures of the thorax, head, and neck, and are associated with extremely poor outcomes. Rare cases originating from salivary glands have been reported with clinicopathologic features comparable to NUT carcinoma of other sites. Outcome studies regarding this subgroup are currently lacking. We report a case of NUT carcinoma arising in a submandibular gland of a 12-year-old boy. Diagnosis was confirmed by fluorescence in situ hybridization demonstrating fusion of the BRD4 (19p13.12) and NUTM1 (15q14) gene loci. A systematic review of all previously reported salivary gland NUT carcinomas (n = 15) showed exclusive occurrence of pediatric cases (n = 6) in males compared to adult patients (n = 9, male: female = 1:2; p < 0.05). The median survival was 24 and 4 months for pediatric and adult patients, respectively (95% confidence interval was 8-24 and 1-7 months, respectively; p < 0.01). The 1-year overall survival was 67% for pediatric and 11% for adult patients. Among all NUT carcinomas, pediatric salivary gland tumors may represent a distinct clinical subset associated with male predilection and comparatively prolonged survival.Entities:
Keywords: BRD4-NUTM1; NUT; Pediatric; Salivary gland tumor; Survival
Year: 2020 PMID: 32077054 PMCID: PMC8010040 DOI: 10.1007/s12105-020-01141-3
Source DB: PubMed Journal: Head Neck Pathol ISSN: 1936-055X